1h Free Analyst Time
The epinephrine autoinjector market is forecasted to grow by USD 2.44 billion during 2023-2028, accelerating at a CAGR of 10.59% during the forecast period. The report on the epinephrine autoinjector market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies, rising innovations in marketing strategies by vendors, and rise in awareness of anaphylaxis and availability of innovative epinephrine autoinjectors.
The epinephrine autoinjector market is segmented as below:
By Type
- 0.30gm
- 0.15gm
- 0.50gm
By End-user
- Hospitals
- clinics
- Homecare
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the epinephrine autoinjector market covers the following areas:
- Epinephrine autoinjector market sizing
- Epinephrine autoinjector market forecast
- Epinephrine autoinjector market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global epinephrine autoinjector market: Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., kaleo Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is frequent product launches due to government pressure on vendors.'
According to the report, one of the major drivers for this market is the increasing prevalence of allergies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adamis Pharmaceuticals Corp.
- ALK Abello AS
- Amneal Pharmaceuticals Inc.
- Bausch Health Companies Inc.
- BIOPROJET
- Crossject
- Halozyme Therapeutics Inc.
- kaleo Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
